MRI透视触发造影剂团追踪技术在小肝癌增强扫描中的应用  

Application of MRI Fluoroscopic Triggered Bolustrak in Small Hepatocellular Carcinoma

作　　者：葛雅丽[1] 郑敏文[1] 张劲松[1] 韩月东[1] 卢成哲[1] 宦怡[1] 

机构地区：[1]第四军医大学西京医院放射科,陕西西安710032

出　　处：《实用放射学杂志》2003年第4期365-366,372,共3页Journal of Practical Radiology

摘　　要：目的　探讨透视触发造影剂团追踪 (FTB)技术在小肝癌 (SHCC)多期扫描中的临床应用价值。方法　 2 0例临床及其它检查诊断或可疑小肝癌的患者。分成 2组 ,对照组 1 0例按常规方法进行增强扫描 ,实验组 1 0例增强扫描前采用FTB技术 ,监测出主动脉及心脏内造影剂浓度从无到有的变化过程图后 ,再接着进行增强扫描。结果　对照组仅 3例获得较好动脉期 ,确诊小肝癌 3例 ;实验组所有病例均获得最佳动脉期 ,检出小肝癌 7例 ,1 0例确诊的小肝癌均得到手术及病理的证实。Objective To investigate the application value of MRI fluoroscopic triggered bolustrak (FTB)in detecting small hepatocellular carcinoma (SHCC).Methods Twenty patients suspected SHCC underwent MRI examination. 10 cases were performed conventional contrast enhanced scanning, the other 10 cases were performed FTB technique scanning.Results Only 3 cases got artery phase images and were diagnosed as SHCC in control while 7 cases got optimal artery phase by using FTB technique. Conclusion FTB technique permit great improve of the diagnosis of SHCC.

关 键 词：MRI 透视触发造影剂团追踪技术 小肝癌 增强扫描 

分 类 号：R734.204[医药卫生—肿瘤]